{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:58:02Z","timestamp":1791579482518,"version":"4.3.4"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"publisher","award":["Grant\/Award Numbers: MOST 109-2221-E-002-083-"],"award-info":[{"award-number":["Grant\/Award Numbers: MOST 109-2221-E-002-083-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2221-E-002-163-"],"award-info":[{"award-number":["MOST 108-2221-E-002-163-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["Grant\/Award Numbers: 109-EDN11"],"award-info":[{"award-number":["Grant\/Award Numbers: 109-EDN11"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["109-S4579"],"award-info":[{"award-number":["109-S4579"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["109-O20"],"award-info":[{"award-number":["109-O20"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108EDN02"],"award-info":[{"award-number":["108EDN02"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108-N4406"],"award-info":[{"award-number":["108-N4406"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["107-EDN11"],"award-info":[{"award-number":["107-EDN11"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["Grant\/Award Numbers: MOST 109\u20102221\u2010E\u2010002\u2010083\u2010"],"award-info":[{"award-number":["Grant\/Award Numbers: MOST 109\u20102221\u2010E\u2010002\u2010083\u2010"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108\u20102221\u2010E\u2010002\u2010163\u2010"],"award-info":[{"award-number":["MOST 108\u20102221\u2010E\u2010002\u2010163\u2010"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["Grant\/Award Numbers: 109\u2010EDN11"],"award-info":[{"award-number":["Grant\/Award Numbers: 109\u2010EDN11"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["109\u2010S4579"],"award-info":[{"award-number":["109\u2010S4579"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["109\u2010O20"],"award-info":[{"award-number":["109\u2010O20"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108EDN02"],"award-info":[{"award-number":["108EDN02"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108\u2010N4406"],"award-info":[{"award-number":["108\u2010N4406"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["107\u2010EDN11"],"award-info":[{"award-number":["107\u2010EDN11"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Mineralocorticoid receptor antagonists (MRAs) have been shown to provide survival benefits in patients with heart failure; however, MRA use in patients with chronic kidney disease has been limited by safety concerns. The effects of MRAs on outcomes in patients with end-stage renal disease (ESRD) and heart failure remain unknown. The aim of this study was to evaluate the effects of MRAs on cardiovascular outcomes in patients with heart failure under maintenance dialysis in a real-world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted by collecting data from the Taiwan National Health Insurance Research Database (NHIRD). Patients diagnosed with heart failure and ESRD and who started maintenance dialysis between 1 January 2001 and 31 December 2013 were identified. Patients were grouped according to MRA prescription. The outcomes of interest included cardiovascular (CV) death, hospitalization for heart failure (HHF), all-cause mortality, acute myocardial infarction (AMI), ischaemic stroke, any coronary revascularization procedures, and new-onset hyperkalaemia. Propensity score matching was performed at a 1:3 ratio between MRA users and non-users to minimize selection bias. A total of 50\u2009872 patients who satisfied our inclusion and exclusion criteria were identified. After 1:3 matching, 2176 patients were included in the MRA group, and 6528 patients were included in the non-MRA group. The risk of CV death was significantly lower among patients who received MRAs than those who did not (hazard ratio [HR] 0.88, 95% confidence interval [CI] 0.80\u20130.95), as was the risk of all-cause mortality (HR 0.88, 95% CI 0.83\u20130.94). Reductions in the risks of CV death and all-cause mortality were more prominent among patients undergoing haemodialysis and those with coronary artery disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients undergoing regular dialysis who are diagnosed with heart failure, the use of MRAs is associated with lower risks of all-cause mortality and CV death. The benefits of MRA treatment in heart failure may persist in patients with ESRD. Further investigations through randomized controlled trials are needed to assess the efficacy and safety of MRAs in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.2740","type":"journal-article","created":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T23:30:15Z","timestamp":1668987015000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Effects of Mineralocorticoid Receptor Antagonists on Cardiovascular Outcomes in Patients with End-Stage Renal Disease and Heart Failure"],"prefix":"10.1093","volume":"25","author":[{"given":"Donna Shu-Han","family":"Lin","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , Taipei ,","place":["Taiwan"]},{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch , Hsinchu ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ju","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Medicine, National Taiwan University , Taipei ,","place":["Taiwan"]},{"name":"Department of Pharmacy, National Taiwan University Hospital , Taipei ,","place":["Taiwan"]},{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital , Chiayi ,","place":["Taiwan"]},{"name":"College of Medicine, Graduate Institute of Clinical Medical Sciences, Chang Gung University , Taoyuan City ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Kuang","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , Taipei ,","place":["Taiwan"]},{"name":"Department of Internal Medicine, National Taiwan University College of Medicine , Taipei ,","place":["Taiwan"]},{"name":"Department of Laboratory Medicine, National Taiwan University College of Medicine , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , Taipei ,","place":["Taiwan"]},{"name":"Department of Laboratory Medicine, National Taiwan University College of Medicine , Taipei ,","place":["Taiwan"]},{"name":"Cardiovascular Center, National Taiwan University Hospital , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,11]]},"reference":[{"key":"2026010913080727500_ejhf2740-bib-0001","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","journal-title":"Lancet"},{"key":"2026010913080727500_ejhf2740-bib-0002","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"2026010913080727500_ejhf2740-bib-0003","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0004","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2019.02.071","article-title":"Burden and outcomes of heart failure hospitalizations in adults with chronic kidney disease","volume":"73","author":"Bansal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.jacc.2019.09.059","article-title":"Impact of renal impairment on beta-blocker efficacy in patients with heart failure","volume":"74","author":"Kotecha","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid management in patients with chronic kidney disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026010913080727500_ejhf2740-bib-0007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/sdi.12878","article-title":"Heart failure management in dialysis patients: many treatment options with no clear evidence","volume":"33","author":"Roehm","year":"2020","journal-title":"Semin Dial"},{"key":"2026010913080727500_ejhf2740-bib-0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026010913080727500_ejhf2740-bib-0009","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026010913080727500_ejhf2740-bib-0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"2026010913080727500_ejhf2740-bib-0011","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/ehs361","article-title":"Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients","volume":"34","author":"Drechsler","year":"2013","journal-title":"Eur Heart J"},{"key":"2026010913080727500_ejhf2740-bib-0012","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2215\/CJN.13221019","article-title":"Mineralocorticoid receptor antagonists in ESKD","volume":"15","author":"Agarwal","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026010913080727500_ejhf2740-bib-0013","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000441262","article-title":"Mineralocorticoid receptor antagonists in end-stage renal disease: efficacy and safety","volume":"41","author":"Bomback","year":"2016","journal-title":"Blood Purif"},{"key":"2026010913080727500_ejhf2740-bib-0014","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.kint.2018.11.025","article-title":"A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients","volume":"95","author":"Hammer","year":"2019","journal-title":"Kidney Int"},{"key":"2026010913080727500_ejhf2740-bib-0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jch.12628","article-title":"Long-term effects of low-dose spironolactone on chronic dialysis patients: a randomized placebo-controlled study","volume":"18","author":"Lin","year":"2016","journal-title":"J Clin Hypertens"},{"key":"2026010913080727500_ejhf2740-bib-0016","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0017","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.kint.2018.08.034","article-title":"Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial","volume":"95","author":"Charytan","year":"2019","journal-title":"Kidney Int"},{"key":"2026010913080727500_ejhf2740-bib-0018","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2215\/CJN.12371214","article-title":"The safety of eplerenone in hemodialysis patients: a noninferiority randomized controlled trial","volume":"10","author":"Walsh","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026010913080727500_ejhf2740-bib-0019","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","article-title":"Nationwide population science: lessons from the Taiwan National Health Insurance Research Database","volume":"175","author":"Hsing","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026010913080727500_ejhf2740-bib-0020","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018062","article-title":"Data resource profile: the National Health Insurance Research Database (NHIRD)","volume":"40","author":"Lin","year":"2018","journal-title":"Epidemiol Health"},{"key":"2026010913080727500_ejhf2740-bib-0021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan's National Health Insurance Research Database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"key":"2026010913080727500_ejhf2740-bib-0022","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods","volume":"162","author":"Zhou","year":"2005","journal-title":"Am J Epidemiol"},{"key":"2026010913080727500_ejhf2740-bib-0023","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of acute myocardial infarction cases in the National Health Insurance Research Database in Taiwan","volume":"24","author":"Cheng","year":"2014","journal-title":"J Epidemiol"},{"key":"2026010913080727500_ejhf2740-bib-0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","article-title":"Validating the diagnosis of acute ischemic stroke in a National Health Insurance Claims Database","volume":"114","author":"Hsieh","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"2026010913080727500_ejhf2740-bib-0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026010913080727500_ejhf2740-bib-0026","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/sim.8008","article-title":"Propensity-score matching with competing risks in survival analysis","volume":"38","author":"Austin","year":"2019","journal-title":"Stat Med"},{"key":"2026010913080727500_ejhf2740-bib-0027","first-page":"392","article-title":"Spironolactone in chronic hemodialysis patients improves cardiac function","volume":"20","author":"Taheri","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026010913080727500_ejhf2740-bib-0028","first-page":"507","article-title":"A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced congestive heart failure on continuous ambulatory peritoneal dialysis","volume":"23","author":"Taheri","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026010913080727500_ejhf2740-bib-0029","first-page":"45","article-title":"Effects of spironolactone on cardiovascular complications in hemodialysis patients of Taleghani hospital during the period of 2016\u20132017: a randomized double-blind controlled clinical trial","volume":"20","author":"Ziaee","year":"2019","journal-title":"Iran Heart J"},{"key":"2026010913080727500_ejhf2740-bib-0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","article-title":"Long-term effects of spironolactone in peritoneal dialysis patients","volume":"25","author":"Ito","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2026010913080727500_ejhf2740-bib-0031","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1753944715591448","article-title":"Spironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patients","volume":"9","author":"Feniman-De-Stefano","year":"2015","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2026010913080727500_ejhf2740-bib-0032","volume-title":"USRDS Annual Data Report: Epidemiology of kidney disease in the United States","author":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases","year":"2021"},{"key":"2026010913080727500_ejhf2740-bib-0033","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.110.957480","article-title":"A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction","volume":"4","author":"Lee","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026010913080727500_ejhf2740-bib-0034","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2215\/CJN.15841020","article-title":"Efficacy and safety of mineralocorticoid receptor antagonists in kidney failure patients treated with dialysis: a systematic review and meta-analysis","volume":"16","author":"Chen","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026010913080727500_ejhf2740-bib-0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000504040","article-title":"Association between dialysis modality and cardiovascular diseases: a comparison between peritoneal dialysis and hemodialysis","volume":"49","author":"Banshodani","year":"2020","journal-title":"Blood Purif"},{"key":"2026010913080727500_ejhf2740-bib-0036","article-title":"Hemodialysis versus peritoneal dialysis: a comparison of survival outcomes in South-East Asian patients with end-stage renal disease","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"2026010913080727500_ejhf2740-bib-0037","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s11255-020-02683-9","article-title":"Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis","volume":"53","author":"Ng","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"2026010913080727500_ejhf2740-bib-0038","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/ndt\/gfaa282","article-title":"Impact of dialysis modality on major adverse cardiovascular events and all-cause mortality: a national population-based study","volume":"36","author":"Hu","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026010913080727500_ejhf2740-bib-0039","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1038\/s41598-019-42508-z","article-title":"Comparative study of peritoneal dialysis versus hemodialysis on the clinical outcomes in Korea: a population-based approach","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"2026010913080727500_ejhf2740-bib-0040","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 annual data report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026010913080727500_ejhf2740-bib-0041","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026010913080727500_ejhf2740-bib-0042","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026010913080727500_ejhf2740-bib-0043","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"2026010913080727500_ejhf2740-bib-0044","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00395-017-0643-0","article-title":"Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs","volume":"112","author":"Li","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2005.03.078","article-title":"Eplerenone suppresses neointimal formation after coronary stent implantation in swine","volume":"107","author":"Wakabayashi","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0046","doi-asserted-by":"crossref","first-page":"769","DOI":"10.47102\/annals-acadmedsg.Hurkan","article-title":"Spironolactone does not prevent restenosis after coronary stenting in humans","volume":"33","author":"Kursaklioglu","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"2026010913080727500_ejhf2740-bib-0047","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.22528","article-title":"Vascular effects of eplerenone in coronary artery disease with preserved ejection fraction: a double-blind, randomized, placebo-controlled trial","volume":"39","author":"Sudano","year":"2016","journal-title":"Clin Cardiol"},{"key":"2026010913080727500_ejhf2740-bib-0048","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/HJH.0b013e3282e9a72d","article-title":"Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure","volume":"25","author":"Shah","year":"2007","journal-title":"J Hypertens"},{"key":"2026010913080727500_ejhf2740-bib-0049","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/europace\/eup314","article-title":"Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization","volume":"11","author":"Pascale","year":"2009","journal-title":"Europace"},{"key":"2026010913080727500_ejhf2740-bib-0050","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026010913080727500_ejhf2740-bib-0051","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026010913080727500_ejhf2740-bib-0052","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.2740","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.2740","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/1\/98\/65493516\/eurjhf_25_1_98.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/1\/98\/65493516\/eurjhf_25_1_98.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:10:03Z","timestamp":1767982203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/25\/1\/98\/8341700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,11]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.2740","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1]]},"published":{"date-parts":[[2022,12,11]]},"assertion":[{"value":"2022-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}